Prosecution Insights
Prosecution Insights
Tech Center 3700 • Art Units: 3791
This examiner grants 26% of resolved cases
Martin Nathan Ortega serves in Tech Center 3700 and Art Unit 3791, with 81 resolved cases. The allowance rate is 25.9%, which is low and suggests a difficult path for applicants. The median days to allowance is 1442, indicating that the cases that do reach allowance take a long time to do so. This 1442-day figure, combined with the 25.9% success rate, highlights the rigorous nature of examination in this unit.
However, the interview lift is a substantial 34.2%. This 34.2% lift is a key metric in the profile, as it increases the likelihood of success compared to the 25.9% baseline. For the 81 resolved cases, this data suggests that direct engagement is an effective strategy for overcoming rejections. Practitioners should prioritize interviews during the 1442-day median pendency to take advantage of this 34.2% lift and improve their chances in a challenging environment.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18141186 | ELECTRONIC DEVICE FOR SLEEP MONITORING AND OPERATING METHOD THEREOF | Final Rejection | Samsung Electronics Co., Ltd. |
| 17900678 | Adjustment or Weighting of Blood Pressure in Response to One or More Biophysical or Environmental Conditions | Final Rejection | Apple Inc. |
| 17814798 | MASK FOR NON-CONTACT RESPIRATORY MONITORING | Non-Final OA | Covidien LP |
| 19003007 | ANALYTE SENSORS AND SENSING METHODS FOR DUAL DETECTION OF GLUCOSE AND ETHANOL | Non-Final OA | Abbott Diabetes Care Inc. |
| 18456951 | SYSTEM, APPARATUS, AND DEVICES FOR ANALYTE MONITORING | Non-Final OA | ABBOTT DIABETES CARE INC. |
| 17556923 | SYSTEMS AND METHODS FOR ANALYTE DETECTION | Non-Final OA | ABBOTT DIABETES CARE INC. |
| 17478447 | DIGITAL AND USER INTERFACES FOR ANALYTE MONITORING SYSTEMS | Non-Final OA | ABBOTT DIABETES CARE INC. |
| 17309197 | PHYSICAL FITNESS TRAINING SYSTEMS AND METHODS | Non-Final OA | Abbott Diabetes Care Inc. |
| 18015620 | INTRALUMINAL PHYSIOLOGY SENSING DEVICE WITH EMBEDDED CONFORMAL CONDUCTORS | Final Rejection | KONINKLIJKE PHILIPS N.V. |
| 17943394 | WIRELESS TECHNOLOGIES FOR HEALTH MONITORING | Non-Final OA | INTEL CORPORATION |
| 17633749 | Neurofeedback Training to Promote Sharp Wave Ripples | Final Rejection | The Regents of the University of California |
| 19094722 | Systems and Methods for Predictive Glucose Management | Non-Final OA | The Board of Trustees of the Leland Stanford Junior University |
| 18077846 | SYSTEMS AND METHODS FOR POWERING AUTONOMOUS SWEAT SENSOR | Non-Final OA | California Institute of Technology |
| 17047055 | APPARATUS, SYSTEM AND METHOD TO PROVIDE A PLATFORM TO OBSERVE BODILY FLUID CHARACTERISTICS FROM AN INTEGRATED SENSOR STRIP | Final Rejection | JABIL INC. |
| 17445915 | SYSTEM AND METHOD FOR CONCUSSIVE IMPACT MONITORING | Non-Final OA | New York University |
| 18960126 | COMPRESSION EVENT DETECTION FOR CONTINUOUS GLUCOSE MONITORS | Non-Final OA | Dexcom, Inc. |
| 17821902 | HYPOTENSION PREDICTION WITH ADJUSTABLE HYPOTENSION THRESHOLD | Non-Final OA | Becton, Dickinson and Company |
| 18320832 | DEVICES, SYSTEMS, AND METHODS FOR OPTIMIZING MEDICAL PROCEDURES AND OUTCOMES | Non-Final OA | Orthosensor Inc. |
| 18102763 | WEARABLE ELASTIC BIO-SENSORS FOR IMPROVED EMERGENCY CARE | Non-Final OA | VOC HEALTH, INC. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy